{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9NZ94",
      "entity_text" : "NLGN3",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0095" ],
      "CellLine" : [ "uaz:UA-CLine-5317" ],
      "Cellular_component" : [ "go:GO:0005925" ],
      "Organ" : [ "uberon:UBERON:0000479" ],
      "Species" : [ "taxonomy:9606" ],
      "CellType" : [ "cl:CL:0000540" ]
    }
  },
  "verbose_text" : "In GBM patients NLGN3 levels are high in the deep brain, preparing a pro GBM tumor microenvironment.",
  "reading_complete" : "2020-08-04T12:27:11Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T12:24:52Z",
  "trigger" : "levels",
  "evidence" : [ "NLGN3 levels" ],
  "pmc_id" : "7105615",
  "score" : 0
}